Skip to main content

Table 6 Univariate and multivariate Cox analysis of OS among patients who received EGFR-TKI treatment

From: Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

 

Univariate analysis

Multivariate analysis

HR

95%CI

P

HR

95%CI

P

Platelet

 (Decrease VS Increase)

0.311

0.118-0.818

0.018

0.293

0.107-0.799

0.017

D-dimer

 (Decrease VS Increase)

0.538

0.204-1.416

0.209

   

 Male VS Female

0.207

0.059-0.724

0.014

0.195

0.042-0.914

0.038

 Age (≥62.5 vs. others)

1.937

0.716-5.240

0.193

   

Substitution in exon 21

 (Yes vs. No)

1.008

0.355-2.867

0.988

   

Deletion in exon 19

 (Yes vs. No)

1.150

0.443-2.987

0.774

   

 Smoking(Yes vs. No)

2.931

1.112-7.730

0.030

0.695

0.199-2.422

0.568

Other treatment

 (Yes vs. No)

0.500

0.192-1.300

0.155

   

Other diseases

 (Yes vs. No)

2.92

1.079-7.901

0.035

2.796

0.970-8.059

0.057

  1. OS overall survival, HR hazard ratio